This inventor holds 1 USPTO granted patent. Top assignee: Yuyu Pharma, Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations by Tae Gon Baik in Pharmaceutical Composition
Introduction
Tae Gon Baik is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of drugs that enhance patient compliance and stability.
Latest Patents
Tae Gon Baik holds a patent for a pharmaceutical composition comprising dutasteride and propylene glycol monolaurate. This invention improves the stability of dutasteride, a poorly soluble drug used as a 5-alpha reductase inhibitor. The patent describes a capsule formulation that is smaller in size than the commercial dutasteride capsule formulation (AVODART®) while maintaining an equivalent dissolution rate. This innovative approach enhances the stability of dutasteride, ultimately leading to improved patient compliance.
Career Highlights
Tae Gon Baik is associated with Yuyu Pharma, Inc., where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation has positioned him as a key player in the industry.
Collaborations
Tae Gon Baik collaborates with talented individuals such as Seyeon Kim and Kyeongjin Ahn, contributing to the advancement of pharmaceutical research and development.
Conclusion
Tae Gon Baik's work in pharmaceutical composition exemplifies the importance of innovation in improving drug stability and patient compliance. His contributions are paving the way for advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile